These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1355678

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.
    Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurr NK.
    Carcinogenesis; 1991 Sep; 12(9):1533-7. PubMed ID: 1680031
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
    Torkaman-Boutorabi A, Hoormand M, Naghdi N, Bakhshayesh M, Milanian I.
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
    [Abstract] [Full Text] [Related]

  • 27. Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls.
    Dolzan V, Rudolf Z, Breskvar K.
    Carcinogenesis; 1995 Nov; 16(11):2675-8. PubMed ID: 7586185
    [Abstract] [Full Text] [Related]

  • 28. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls.
    Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I.
    Cancer Res; 1993 Mar 01; 53(5):1004-11. PubMed ID: 8439946
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.
    Romkes-Sparks M, Mnuskin A, Chern HD, Persad R, Fleming C, Sibley GN, Smith P, Wilkinson GR, Branch RA.
    Carcinogenesis; 1994 Sep 01; 15(9):1955-61. PubMed ID: 7923590
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
    Cascorbi I, Brockmöller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I.
    Cancer Res; 1996 Sep 01; 56(17):3961-6. PubMed ID: 8752164
    [Abstract] [Full Text] [Related]

  • 36. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
    Evans WE, Relling MV.
    Mol Pharmacol; 1990 May 01; 37(5):639-42. PubMed ID: 1971090
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. pNAT and CYP2D6 gene polymorphism in epileptic patients.
    Borlak JT, Harsany V, Schneble H, Haegele KD.
    Biochem Pharmacol; 1994 Nov 01; 48(9):1717-20. PubMed ID: 7980640
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
    Lemos MC, Cabrita FJ, Silva HA, Vivan M, Plácido F, Regateiro FJ.
    Carcinogenesis; 1999 Jul 01; 20(7):1225-9. PubMed ID: 10383893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.